Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study

被引:0
|
作者
Henrik Svanström
Marie Lund
Mads Melbye
Björn Pasternak
机构
[1] Statens Serum Institut,Department of Epidemiology Research
[2] University of Copenhagen,Department of Clinical Medicine
[3] Stanford University School of Medicine,Department of Medicine
[4] Karolinska Institutet,Clinical Epidemiology Unit, Department of Medicine Solna
来源
Drug Safety | 2018年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:817 / 826
页数:9
相关论文
共 50 条
  • [1] Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study
    Svanstrom, Henrik
    Lund, Marie
    Melbye, Mads
    Pasternak, Bjorn
    DRUG SAFETY, 2018, 41 (08) : 817 - 826
  • [2] Use of proton pump inhibitors and risk of acute kidney injury among patients with rheumatoid arthritis
    Svanstrom, Henrik
    Lund, Marie
    Melbye, Mads
    Pasternak, Bjorn
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 453 - 453
  • [3] PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY
    Munch, Philip Vestergaard
    Norgaard, Mette
    Heide-Jorgensen, Uffe
    Jensen, Simon Kok
    Birn, Henrik
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1063 - I1063
  • [4] Risk of acute kidney injury in patients with HIV receiving proton pump inhibitors
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H.
    Hardin, James W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (10) : 781 - 790
  • [5] Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population--based cohort study
    Abtahi, Shahab
    Driessen, Johanna H. M.
    Burden, Andrea M.
    Souverein, Patrick C.
    van den Bergh, Joop P.
    van Staa, Tjeerd P.
    Boonen, Annelies
    de Vries, Frank
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04) : 423 - 431
  • [6] Use of Proton Pump Inhibitors and Risk of Hip/knee Joint Replacement Among Patients with Osteoarthritis and Rheumatoid Arthritis
    Sangaraju, Koushik
    Grovu, Radu
    Kwark, Michael
    Cohen, Elizabeth
    Hassan, Amira
    Slobodnick, Anastasia
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 627 - 628
  • [7] Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'
    Gong, Zhen
    Zhang, Fangjie
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E142 - E142
  • [8] Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'
    Zheng, Bing-kun
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04)
  • [9] Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study
    Hart, Emily
    Dunn, Terry E.
    Feuerstein, Steven
    Jacobs, David M.
    PHARMACOTHERAPY, 2019, 39 (04): : 443 - 453
  • [10] Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis
    Sugiyama, Toshihiro
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09)